Cofirasersen sodium is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
Molekulargewicht:
5789.18
Formel:
C172H202N57Na16O88P15S15
Target-Kategorie:
Sodium Channel
Anwendungsbeschreibung:
Oligonucleotides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
